Portfolio

Accumetrics is a developer and manufacturer of point of care diagnostics in the cardiovascular and neurovascular disease areas.

Acquired by ITC Nexus in 2013.

AcroMetrix is a leading developer and manufacturer of controls and standards for molecular diagnostic tests.

Acquired by Life Technologies in 2010.

Agena Bioscience is a life sciences and clinical diagnostics company that offers the MassARRAY® System for nucleic acid detection.

Acquired by Mesa Laboratories in 2021.

Akoya Biosciences enables high-parameter, deep proteomic profiling of tissues.

Initial public offering in 2021 (NASDAQ:AKYA).

Althea Technologies is a provider of contract manufacturing and services to the pharmaceutical and biotechnology industry.

Acquired by Ajinomoto in 2013.

AltheaDx is a commercial stage molecular diagnostics company specializing in the field of pharmacogenetics.

Ambion is a leader in RNA-based life science research products for handling, preserving, isolating, detecting and measuring RNA.

Acquired by Applied Biosystems Group in 2006.

AngioScore develops, makes and sells leading edge tools for endovascular therapy.

Acquired by The Spectranetics Corporation in 2014.

Applied Precision is a leading provider of imaging, measurement and analysis systems for the life sciences industry and OEM markets.

Acquired by GE in 2011.

Aquaro Histology provides technology to help improve safety, efficiency, and consistency in sample preparation workflow.

Argonaut provides reagent and consumable contract manufacturing services for Molecular Diagnostic and Life Science companies.

Asuragen leverages RNA expertise to focus on emerging opportunities in personalized medicine for cancer patients, creating novel diagnostic products that facilitate early diagnosis and treatment outcome.

Acquired by Bio-Techne in 2021.

Aurora Discovery develops and markets premium high-density microplates for high-throughput screening, live cell imaging and other applications.

Acquired by NEXUS Biosystems in 2009.

Carterra develops high throughput analytical instruments for the printing and reading of protein binding arrays.

Cell Microsystems’ products enable analysis and isolation of single cells with high viability and yield for discovery and translational research applications.

Confirma is a pioneer and leader in application-specific computer-aided-detection for MRI.

Acquired by Merge Healthcare in 2009.

Dharmacon is the global leader in synthetic RNA and related technologies.

Acquired by Fisher Scientific in 2004.

Dynex is a leading designer and manufacturer of automated ELISA microplate workstations, laboratory instruments, consumables and accessories.

ETS provides analytical software tools and outsourced services to insurance providers and other payers to manage expensive cell and gene therapies.

Estech develops medical devices that enable less invasive cardiac surgery including coronary artery bypass grafts, valve repair and cardiac tissue ablation.

Acquired by AtriCure, Inc. in 2014.

Excellos provides cellular products and services to scientists and clinicians working with cell and gene therapies.

Freedom Innovations develops, manufactures and markets premium, advanced technology prosthetic devices for lower limb amputees.

Acquired by Health Evolution Partners in 2012.

Frontier Psychiatry is a telehealth provider of psychiatry and addiction medicine services with a focus on delivering quality care to rural and frontier communities.

GrayHawk Health is a value-based provider partnering with health insurance companies, ACOs and health systems to close gaps in care and keep populations of high-risk patients well and out of the hospital through home-based and remote care management.

Interface specializes in catheter production machines, complex medical balloon development and contract balloon manufacturing.

Acquired by NDC in 2015.

InvisAlert Solutions develops software and hardware based technology solutions to improve patient safety in behavioral healthcare settings.

Kinetikos Medical develops products for small bone surgery including advanced joint replacement implants and fixation and surgical devices.

Acquired by Integra Life Sciences in 2006.

LDR develops and markets innovative fusion and non-fusion spinal implants to surgeons and patients. Initial public offering in 2013 (NASDAQ:LDRH).

Acquired by Zimmer Biomet in 2016.

Magstim is a pioneer in neural stimulation and intraoperative nerve monitoring. The company’s trans-cranial magnetic stimulation device has FDA approval for treatment of major depressive disorder.

MedPricer provides a tech-enabled sourcing service for hospitals to bring the benefits of real-time competition to contracting, resulting in significant cost savings and dramatically reduced negotiation periods.

Acquired by Premier, Inc. in 2019

Mosaic Biosciences is a provider of comprehensive protein and antibody therapeutic discovery and development services.

NEXUS Biosystems provides automation systems for sample storage and management to pharma/biotech and academic research institutions.

Acquired by Brooks Automation in 2011.

Nimble Therapeutics is bringing the power of massively parallel chemical synthesis to drug discovery.

Nivagen develops and markets specialty and generic prescription drugs and over the counter products.

Panome Bio provides comprehensive discovery services to profile the metabolome and proteome for research in disease and drug development.

PneumRx develops medical devices that assist in minimally invasive treatment of lung diseases.

Acquired by BTG Plc in 2014.

Precision NanoSystems develops innovative tools and processes to formulate and manufacture nanoparticles used as medicines and in medical research.

Acquired by Danaher in 2021.

RareCyte develops technologies focused on the detection of rare cellular events, beginning with circulating tumor cells.

A leading provider of novel research models and support services. SAGE specializes in genetic manipulation of in vivo systems for R&D applications.

Acquired by Horizon Discovery in 2014.

Specific Diagnostics utilizes unique sensor technology to enable rapid, cost effective, high throughput clinical microbiology diagnostic products, starting with the Reveal rapid susceptibility test platform.

Acquired by bioMérieux in 2022.

SwitchGear Genomics provides technologies and reagents for understanding gene regulation and function.

Acquired by Active Motif in 2013.

Teknova manufactures custom research and GMP reagents for the production of molecular diagnostics, novel vaccines, and next generation therapies, focusing on quality, speed, and service.

Initial Public Offering in 2021 (NASDAQ:TKNO)

TrakCel offers a unique software platform that facilitates efficiency in cell and gene therapy by providing a solution to collate, track and document program-critical information.

Verogen is a forensic science company leveraging next generation sequencing to serve the needs of law enforcement, criminal justice and national security organizations.

Acquired by Qiagen in 2023.

VidaCare’s platform provides rapid access to bone for applications that include emergency vascular access and bone marrow aspiration and biopsy.

Acquired by Teleflex in 2013.

Email

Address